The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development

Francesca Bernassola; Michael Karin; Aaron Ciechanover; Gerry Melino

doi:10.1016/j.ccr.2008.06.001

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

Ubiquitin ligases as therapeutic targets in HIV-1 infection

Jörg Votteler, Ulrich Sigmar Schubert

Article2006

Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change

Ewen Gallagher, Min Gao, Yun‐Cai Liu, Michael Karin

Article2008

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

Philip O'Brien, Michael J. Davies, James Scurry, A N Smith, Caroline Barton, Michelle J. Henderson, Darren N. Saunders, Brian Gloss, Kate Patterson, Jennifer L. Clancy, Viola Heinzelmann‐Schwarz, Richard A Scolyer, Y Zeng, Elizabeth D. Williams, L Scurr, Anna DeFazio, David I. Quinn, C. K. W. Watts, Neville F. Hacker, Susan M. Henshall, R. L. Sutherland

Article2011

Identification of the protein kinases that activate the E3 ubiquitin ligase Pellino 1 in the innate immune system

Eddy T. H. Goh, J. Simon C. Arthur, Peter Cheung, Akira Shizuo, Rachel Toth, Philip Cohen

Biochemical Journal

Article2024

Widespread destabilization of<i>C. elegans</i>microRNAs by the E3 ubiquitin ligase EBAX-1

Michael W. Stubna, Aditi Shukla, David Bartel